Psychiatric Services
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Psychiatr Serv 60:294-296, March 2009
doi: 10.1176/appi.ps.60.3.294
© 2009 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Stowell, K. R.
* Articles by Haskett, R. F.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Stowell, K. R.
* Articles by Haskett, R. F.
Related Collections
* Costs, Cost Analysis
* Hospitals, Hospital Treatment
* Quality of Care, Practice Guidelines
* Education, Psychiatrists
* Atypical Neuroleptics

Column

Best Practices: An Intervention to Promote Evidence-Based Prescribing at a Large Psychiatric Hospital

Keith R. Stowell, M.D., M.S.P.H., Frank A. Ghinassi, Ph.D., Tanya J. Fabian, Ph.D., Pharm.D., Kenneth C. Nash, M.D. and Roger F. Haskett, M.D.

The authors are affiliated with Western Psychiatric Institute and Clinic and the Department of Psychiatry, University of Pittsburgh School of Medicine. Dr. Fabian is also with the Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy. Send correspondence to Dr. Ghinassi, Western Psychiatric Institute and Clinic, 3811 O'Hara St., Pittsburgh, PA 15213-2593 (e-mail: ghinassifa{at}upmc.edu). This work was previously presented at the Institute on Psychiatric Services, New Orleans, October 11–14, 2007. William M. Glazer, M.D., is editor of this column.

An intervention to affect prescribing behavior was implemented at a large psychiatric hospital. Articles providing support for appropriate dosing of quetiapine were distributed to physicians, and peer discussions about prescribing practices were held. From April 2005 through December 2006, low-dose quetiapine prescriptions (≤200 mg per day) were flagged. For four months, physicians writing low-dose prescriptions received personal feedback from the unit medical director, who encouraged appropriate alternatives. New low-dose prescriptions fell from 107 in July 2005 to 23 in December 2006. Monthly costs for quetiapine prescriptions declined by approximately $8,000. The intervention appeared to bring physicians' behavior more in line with evidence-based practices.







Get information about faster international access.

Privacy Policy

Copyright © 2009 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org